Partner with Nebu~Flow
We’re seeking partners who share our vision of transforming drug delivery. Our proprietary technology platform enables inhaled delivery of tomorrow’s most exciting biologic therapeutics, to change how life-threatening and life-limiting conditions are treated.

How we can help you achieve your goals
A patented technology platform designed to gently aerosolise fragile biologics and other hard-to-nebulise drugs for inhaled delivery.
Market exclusivity through new drug-device combinations, with extended protection for the pharma industry.
A more efficient and economical route to clinical trials and into the market, due to easier dose adaptation, better data and digital biomarkers that enable smarter trial design.
A cost-effective, sustainable solution for drug delivery, through low wastage and eco-friendly design.
Deep market research and engagements with healthcare providers, patients and carers.

Adding IP protection
With five patent families secured for protection through 2040+, Nebu~Flow can provide better and longer term protection for drug-device combination products, than other products on the market.
Tailored droplet size for unique drug delivery efficiency
Breath actuation
Low drug volume
Design protection such as RFID tag or key/lock for drug ampule

Ensuring sustainability
We aim to be a values-driven company, while committing to environmentally responsible manufacturing practices, product innovation and sustainable growth. Our commitments include:
Reducing drug wastage to less than 5%
Reducing plastic waste through recyclable materials
Measuring and comparing baseline emissions
Achieving net zero emissions by 2050

About Nebu~Flow
We’re an ambitious, award-winning med-tech start-up, founded in 2019 and based in Glasgow, UK. We’ve built momentum with high-value pharma collaborations and £11.2m of funding to date. With five patent families secured, prototype devices validated and active engagement with patients, carers and healthcare providers, we’re on course to deliver a more effective, efficient and sustainable platform for tomorrow’s life-changing therapies.

